Stasiowski, M.J.; Pluta, A.; Lyssek-Boroń, A.; Król, S.; Krawczyk, L.; Niewiadomska, E.; Żak, J.; Kawka, M.; Dobrowolski, D.; Grabarek, B.O.;
et al. Adverse Events during Vitreoretinal Surgery under Adequacy of Anesthesia Guidance—Risk Factor Analysis. Pharmaceuticals 2022, 15, 237.
https://doi.org/10.3390/ph15020237
AMA Style
Stasiowski MJ, Pluta A, Lyssek-Boroń A, Król S, Krawczyk L, Niewiadomska E, Żak J, Kawka M, Dobrowolski D, Grabarek BO,
et al. Adverse Events during Vitreoretinal Surgery under Adequacy of Anesthesia Guidance—Risk Factor Analysis. Pharmaceuticals. 2022; 15(2):237.
https://doi.org/10.3390/ph15020237
Chicago/Turabian Style
Stasiowski, Michał Jan, Aleksandra Pluta, Anita Lyssek-Boroń, Seweryn Król, Lech Krawczyk, Ewa Niewiadomska, Jakub Żak, Magdalena Kawka, Dariusz Dobrowolski, Beniamin Oskar Grabarek,
and et al. 2022. "Adverse Events during Vitreoretinal Surgery under Adequacy of Anesthesia Guidance—Risk Factor Analysis" Pharmaceuticals 15, no. 2: 237.
https://doi.org/10.3390/ph15020237
APA Style
Stasiowski, M. J., Pluta, A., Lyssek-Boroń, A., Król, S., Krawczyk, L., Niewiadomska, E., Żak, J., Kawka, M., Dobrowolski, D., Grabarek, B. O., Szumera, I., Koss, M. J., Missir, A., Rejdak, R., & Jałowiecki, P.
(2022). Adverse Events during Vitreoretinal Surgery under Adequacy of Anesthesia Guidance—Risk Factor Analysis. Pharmaceuticals, 15(2), 237.
https://doi.org/10.3390/ph15020237